Building upon our in vitro findings demonstrating that STING knockdown mitigates HG + PA-induced pro-inflammatory factor release in atrial myocytes, we next investigated its therapeutic potential in vivo using AAV9-mediated myocardial-specific STING knockdown in T2DM mice (Figure 7A). Here, STING1 is linked to type 2 diabetes mellitus.